about
Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subjectCan authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.Pimavanserin for the treatment of Parkinson's disease psychosis.Iloperidone, asenapine and lurasidone: a primer on their current status.Clozapine response and pre-treatment EEG-is there some kind of relationshipClozapine prescribing in the UK: views and experience of consultant psychiatrists.Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future.Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Reintroduction of clozapine after perforation of the large intestine--a case report and review of the literature.Life-threatening haematemesis associated with clozapine: a case report and literature review.Generic atypical antipsychotic drugs in Belgium: their influence and implications.Prevention of haloperidol-induced alterations in brain acetylcholinesterase activity by vitamins B co-administration in a rodent model of tardive dyskinesia.Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.Risk Evaluation and Mitigation Strategy for Clozapine
P2860
Q28073082-E842C7D8-7B9B-49BC-9FFC-CF22CF3F0DC4Q33816182-A56A70A3-CA0F-4A94-A0EC-45782BBBD147Q34369646-0D8E66DC-60BA-4FC3-9DED-151AD9541E92Q34641024-22941D6D-F43A-48FC-AE23-BA21E2BE530AQ34665340-B905204E-5217-42D7-99CA-8FB80F39176CQ35906545-916B8A4D-7BBA-4EE3-8E69-98B5E80CED4EQ36512458-9E6B6027-4567-4653-B145-499B6CA79944Q38062444-296CBBE5-0F1E-4719-8EDE-4DC7D01273ACQ38113770-3DBBD86C-9AC4-4F03-8B44-88D04988E4B5Q38156173-F0F6ED31-ACDB-423C-A4C7-F703A101FF2EQ45809881-9A3F5721-94B6-4EA5-9BF8-FB42EC1BEDBAQ45985326-4CB1169B-9F35-4F20-A113-7DB6375FD431Q51202982-7E8C6D80-7E28-4447-B1EE-1BE3C90EB212Q57820161-79B85E8A-760A-4385-9DF9-5B73BB2FB2A6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clozapine safety, 35 years later.
@ast
Clozapine safety, 35 years later.
@en
Clozapine safety, 35 years later.
@nl
type
label
Clozapine safety, 35 years later.
@ast
Clozapine safety, 35 years later.
@en
Clozapine safety, 35 years later.
@nl
prefLabel
Clozapine safety, 35 years later.
@ast
Clozapine safety, 35 years later.
@en
Clozapine safety, 35 years later.
@nl
P1433
P1476
Clozapine safety, 35 years later.
@en
P2093
Michele Raja
P304
P356
10.2174/157488611797579230
P577
2011-07-01T00:00:00Z